Canada House Wellness Group Inc. builds on Sales License, announces new business structure and the launch of its retail divis...
20 Februar 2019 - 1:00PM
Canada House Wellness Group Inc. (“Canada House” or the “Company”)
(CSE:CHV), building on its newly awarded Sales License, has
announced a major restructuring and future rebranding of its
business to highlight and differentiate its premium products and
services.
An experienced, integrated medical cannabis company providing
patient-specific cannabinoid therapy products and services, Canada
House is aligning its businesses under three verticals: Canada
House Clinics (CHC), Canada House Grow (CHG), and its new retail
arm - Canada House Retail (CHR). Each division clearly defines and
communicates its competitive offering in the marketplace while
delivering on the promise of Quality Cannabis and Quality Care
across all touchpoints.
“Our newly developed brand demonstrates our commitment to
providing leading Cannabinoid Therapy services, unique industry
leading production practices, and now through Canada House Retail,
a clear strategy for the recreational and adult use market,” says
Chris Churchill-Smith, CEO. “CHR will initially house our Edmonton
Dispensary and will be responsible for product development to
address the robust Canadian recreational market and the discerning
cannabis consumer’s interest to have access to high-quality, craft
Cannabis.”
CHC will continue to focus on independent medical cannabis
clinics that help patients renew their lives with medical cannabis,
cannabinoid therapy education, and patient-specific treatment
protocols, while Knalysis, with its sophisticated cannabis patient
management software and data analytics, will continue to improve on
treatment efficacies.
The Canada House Grow (CHG) division, previously Abba Medix, is
a wholly owned and fully licensed LP growing premium medical
cannabis for medical patients and craft cannabis for the new
recreational cannabis division. CHG has licensed the rights in
Canada to Medicine Man Technologies’ commercial production
methodologies for producing premium craft cannabis as well as the
rights in Canada to the Success Nutrients™ line. The CHG division
will also oversee the production of oils and extracts.
Canada House is also excited about the launch of its new retail
division, Canada House Retail (CHR), to market CHG’s craft cannabis
to the Canadian adult use market. Its first dispensary will be
located in Edmonton. CHR will oversee the sales and marketing
efforts of the seeds, genetics, and dried flower.
For further information, please contact: Boom
Capital Markets Steve Low 647-620-5101 steve@boomcapitalmarkets.com
Canada House Wellness Group Inc. Chris Churchill-Smith, CEO
514-313-0102 chris.smith@canadahouse.ca
___________________________________________________________________________
ABOUT CANADA HOUSE WELLNESS GROUP INC. Canada House is an
experienced, integrated medical cannabis company providing
patient-specific cannabinoid therapy products and services through
its clinics and licensed producer. Canada House is the parent
company of Canada House Clinics Inc., Knalysis Technologies and
Abba Medix Corp. For more information, please visit
www.canadahouse.ca or www.sedar.com. Cautionary Statement Regarding
Forward Looking Information. This press release contains
forward-looking statements, including statements that relate to,
among other things, the Company’s clinic, production and technology
businesses, its future plans, the Company’s markets, objectives,
goals, strategies, intentions, beliefs, expectations and estimates,
and can generally be identified by the use of words such as “may”,
“will”, “could”, “should”, “would”, “likely”, “possible”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective”
and “continue” (or the negative thereof) and words and expressions
of similar import. Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed on such statements. Certain
material factors or assumptions are applied in making
forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements.
Material assumptions used to develop forward-looking information in
this news release include, among other things, the regulations
related to cannabis use under the Access to Cannabis for Medical
Purposes Regulations and the act respecting cannabis and to amend
the Controlled Drugs and Substances Act, the Criminal Code and
other Acts, passed by the Canadian Federal government, making
cannabis legal for recreational use by October 17, 2018; Company
liquidity and capital resources, including the availability of
additional capital resources to fund its activities; level of
competition; the ability to adapt products and services to the
changing market; the ability to attract and retain key executives;
and the ability to execute strategic plans. Additional information
about material factors that could cause actual results to differ
materially from expectations and about material factors or
assumptions applied in making forward-looking statements may be
found in the Company’s most recent annual and interim Management’s
Discussion and Analysis under “Risk and Uncertainties” as well as
in other public disclosure documents filed with Canadian securities
regulatory authorities. The Company does not undertake any
obligation to update publicly or to revise any of the
forward-looking statements contained in this document, whether as a
result of new information, future events or otherwise, except as
required by law. Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release.
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
Von Sep 2023 bis Sep 2024